-
Some women with DVT may stop warfarin after six months; Vytorin and cancer; preventing recurrent stroke; and FDA news.
-
The ECG shown above was obtained from a patient who was seen in the office with atypical chest pain. Is there cause for concern?
-
Clinical trials of pharmacotherapy to prevent progression of cognitive decline in those with mild cognitive impairment (MCI) have been disappointing; neither cholinesterase inhibitors (donepezil, rivastigmine, galantamine), vitamin E, nor COX-2 inhibitors has demonstrated any clinically meaningful benefit in placebo-controlled MCI trials.
-
Estrogen treatment (but not estrogen given along with progestin) seems associated with gastro-esophageal reflux (GER) in postmenopausal women. Weight gain increases risk.
-
-
Regardless of where we practice, increasingly we are confronted with patients who have been exposed to unusual diseases through travel. In a previous series of articles, we reviewed the diseases associated with travel, largely based on the geography. This article reviews infectious disease associated with travel by symptoms.
-
The Bush administration announced in August that it was introducing a new regulation on the topic of providers' "conscience" or "refusal" rights.
-
While you might know your work in family planning is important, new research confirms it. Approximately 1.4 million unintended pregnancies and 600,000 abortions are averted each year in the United States each year due to family planning services.
-
While female condoms may be a powerful tool in preventing transmission of sexually transmitted diseases (STDs), women need education to use them effectively. Results from a newly published study indicate that skills training can increase female condom use and the overall level of protected sexual acts.
-
Just-presented research at the XVII International AIDS Conference in Mexico City indicates that adult male circumcision continues to reduce the risk of acquiring HIV through heterosexual intercourse for at least 3.5 years.